The efficacy of TM-β1 (the anti-mouse IL-2Rβ equivalent of Hu-Mik-β1) was evaluated in a mouse model of celiac disease using transgenic mice that express IL-15 in intestinal cells using an enterocyte-specific T3b promoter to drive the transgene (71). The gene discussed is IL15; the disease is celiac disease.